Molina Healthcare (MOH) Stock Rating Upgraded by ValuEngine

ValuEngine upgraded shares of Molina Healthcare (NYSE:MOH) from a hold rating to a buy rating in a report issued on Thursday, November 9th.

MOH has been the topic of several other reports. BidaskClub cut Molina Healthcare from a buy rating to a hold rating in a research note on Friday, August 4th. TheStreet downgraded Molina Healthcare from a b rating to a c rating in a report on Monday, August 7th. Credit Suisse Group reissued an underperform rating and issued a $53.00 target price (up from $50.00) on shares of Molina Healthcare in a report on Friday, July 14th. BMO Capital Markets began coverage on Molina Healthcare in a report on Monday, October 16th. They issued a market perform rating and a $70.00 target price on the stock. Finally, Mitsubishi UFJ Financial Group began coverage on Molina Healthcare in a report on Thursday, September 21st. They issued a neutral rating and a $70.00 target price on the stock. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company’s stock. Molina Healthcare has an average rating of Hold and a consensus target price of $64.30.

Shares of Molina Healthcare (MOH) opened at $74.99 on Thursday. The firm has a market capitalization of $4,286.62, a price-to-earnings ratio of 23.32 and a beta of 0.91. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $80.65. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). The firm had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $4.95 billion. Molina Healthcare had a negative return on equity of 26.38% and a negative net margin of 1.93%. Molina Healthcare’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.85 earnings per share. analysts predict that Molina Healthcare will post -3.88 EPS for the current year.

In other news, insider William Dentino sold 2,000 shares of the company’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $65.08, for a total transaction of $130,160.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director J Mario Md Molina sold 15,000 shares of the company’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $64.75, for a total value of $971,250.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 455,835 shares of company stock worth $31,225,846. Corporate insiders own 6.20% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Zions Bancorporation bought a new position in Molina Healthcare in the third quarter valued at about $118,000. LS Investment Advisors LLC lifted its holdings in Molina Healthcare by 40.9% in the second quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock valued at $127,000 after acquiring an additional 531 shares during the period. Meeder Asset Management Inc. bought a new position in Molina Healthcare in the second quarter valued at about $136,000. Riverhead Capital Management LLC lifted its holdings in Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock valued at $170,000 after acquiring an additional 963 shares during the period. Finally, Sabal Trust CO bought a new position in Molina Healthcare in the third quarter valued at about $206,000. 96.23% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This news story was posted by BBNS and is the sole property of of BBNS. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://baseballnewssource.com/markets/molina-healthcare-inc-moh-upgraded-to-buy-by-valuengine/1771611.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.